BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 541393)

  • 1. Estimation of chlorambucil, phenyl acetic mustard and prednimustine in human plasma by high-performance liquid chromatography.
    Newell DR; Hart LI; Harrap KR
    J Chromatogr; 1979 Sep; 164(1):114-9. PubMed ID: 541393
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the pharmacokinetics of chlorambucil and prednimustine in patients using a new high-performance liquid chromatographic assay.
    Oppitz MM; Musch E; Malek M; Rüb HP; von Unruh GE; Loos U; Mühlenbruch B
    Cancer Chemother Pharmacol; 1989; 23(4):208-12. PubMed ID: 2924378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the pharmacokinetics of chlorambucil and prednimustine in man.
    Newell DR; Calvert AH; Harrap KR; McElwain TJ
    Br J Clin Pharmacol; 1983 Feb; 15(2):253-8. PubMed ID: 6849759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of prednimustine and chlorambucil in the rat.
    Newell DR; Shepherd CR; Harrap KR
    Cancer Chemother Pharmacol; 1981; 6(1):85-91. PubMed ID: 7273268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prednimustine treatment in malignant lymphomas.
    Szántó I; Fleischmann T; Eckhardt S
    Oncology; 1989; 46(4):205-7. PubMed ID: 2662086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol ester formation by transesterification of chlorambucil: a novel pathway in drug metabolism.
    Gunnarsson PO; Johansson SA; Svensson L
    Xenobiotica; 1984 Jul; 14(7):569-74. PubMed ID: 6506771
    [No Abstract]   [Full Text] [Related]  

  • 7. A pharmacokinetic study of prednimustine as compared with prednisolone plus chlorambucil in cancer patients.
    Bastholt L; Johansson CJ; Pfeiffer P; Svensson L; Johansson SA; Gunnarsson PO; Mouridsen H
    Cancer Chemother Pharmacol; 1991; 28(3):205-10. PubMed ID: 1855277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacokinetics of chlorambucil and prednimustine after oral administration.
    Loos U; Musch E; Malek M; Riedel E
    Oncology; 1991; 48(4):334-42. PubMed ID: 1891177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase III study of prednimustine (LEO 1031) in advanced breast cancer. A preliminary report.
    Rørth M; Løber J; Dombernowsky P; Krusenstjerna-Hofstrom D; Mattsson W; Mouridsen HT
    Eur J Cancer (1965); 1980; Suppl 1():137-40. PubMed ID: 7032923
    [No Abstract]   [Full Text] [Related]  

  • 10. The antitumor effect of prednimustine in vitro and in vivo.
    Hartley-Asp B
    Semin Oncol; 1986 Mar; 13(1 Suppl 1):3-7. PubMed ID: 3952519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity and metabolism of prednimustine, chlorambucil and prednisolone in a Chinese hamster cell line.
    Hartley-Asp B; Gunnarsson PO; Liljekvist J
    Cancer Chemother Pharmacol; 1986; 16(2):85-90. PubMed ID: 3948307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prednimustine.
    Semin Oncol; 1986 Mar; 13(1 Suppl 1):1-44. PubMed ID: 3952516
    [No Abstract]   [Full Text] [Related]  

  • 13. A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancer.
    Løber J; Mouridsen HT; Christiansen IE; Dombernowsky P; Mattsson W; Rørth M
    Cancer; 1983 Nov; 52(9):1570-6. PubMed ID: 6352005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prednimustine: the rationale for clinical development.
    Schein PS; Cavalli F
    Semin Oncol; 1986 Mar; 13(1 Suppl 1):1-2. PubMed ID: 3952515
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical trial of prednimustine, Leo-1031 (NSC-134087), in patients with non-Hodgkin lymphomata and chronic lymphocytic leukaemia previously treated with steroids and alkylating agents.
    Pedersen-Bjergaard J; Hansen MM; Geisler CH; Nissen NI
    Acta Med Scand; 1980; 207(3):215-20. PubMed ID: 6989170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-performance liquid chromatographic analysis of chlorambucil tert.-butyl ester and its active metabolites chlorambucil and phenylacetic mustard in plasma and tissue.
    Greig NH; Stahle PL; Shetty HU; Genka S; John V; Soncrant TT; Rapoport SI
    J Chromatogr; 1990 Dec; 534():279-86. PubMed ID: 2094719
    [No Abstract]   [Full Text] [Related]  

  • 17. Prednimustine for prostate cancer therapy.
    Slack NH; Murphy GP
    Compr Ther; 1979 Sep; 5(9):54-7. PubMed ID: 487742
    [No Abstract]   [Full Text] [Related]  

  • 18. Prednimustine in acute nonlymphocytic leukemia.
    Ayulo MA; Preisler HD
    Am J Clin Oncol; 1983 Apr; 6(2):207-9. PubMed ID: 6829495
    [No Abstract]   [Full Text] [Related]  

  • 19. Prednimustine in advanced soft tissue sarcomas.
    Karakousis CP; Didolkar MS; Ambrus JL; Holyoke ED
    Cancer Treat Rep; 1982 Jan; 66(1):201-2. PubMed ID: 7053259
    [No Abstract]   [Full Text] [Related]  

  • 20. Prednimustine in advanced malignant melanoma: a phase II study.
    Pedersen L; Løber J; Dalmark M; Mouridsen HT
    Cancer Treat Rep; 1987 Dec; 71(12):1315-6. PubMed ID: 3690549
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.